I-Screen: an ex vivo human microbiome platform to study microbiome induced reverse metabolism of metabolites back to parent: poster
van de Steeg, E.
Scott Obach, R.
Gut microbiota plays a major role in metabolizing xenobiotics into active, inactive or toxic metabolites, thereby influencing pharmacokinetics, efficacy and toxicity profiles of prescribed drugs, which is currently being underexplored.
To reference this document use:
12th International Society for the Study of Xenobotics (ISSX), 28–31 July 2019, Portland USA